Live News Categoriesmarket

ISSCR (ISSCR) News

Follow ISSCR (ISSCR) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 1 public stories across 1 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol ISSCR Asset market Sector Markets 90 days 0 Updated Jul 06, 2026, 12:30 PM UTC Open live news feed

L Fate Therapeutics to Present Preliminary Clinical Data of FT819 Off-the-Shelf CAR T-Cell Product Candidate for Systemic Sclerosis at the ISS SAN DIEGO, July 06, 2026 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage bio EQUITY | Jul 06, 2026, 12:30 PM UTC